SpyGlass Pharma Inc. Common Stock
SGP | NASDAQ
$32.39
-$0.12 (-0.37%)
At close: Oct 30, 2026, 3:59 PM ET
$32.24
-$0.15 (-0.46%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Revenue | n/a |
Cost of Revenue | 612K |
Gross Profit | -612K |
Operating Income | -41.45M |
Interest Income | 3.11M |
Pretax Income | -39.87M |
Net Income | -39.87M |
Selling & General & Admin | 12.2M |
Research & Development | 28.64M |
Other Expenses | n/a |
Operating Expenses | 40.84M |
Interest Expense | n/a |
Selling & Marketing Expenses | n/a |
Cost & Expenses | 41.45M |
Income Tax Expense | n/a |
Shares Outstanding (Basic) | 31.91M |
Shares Outstanding (Diluted) | 31.91M |
EPS (Basic) | -1.25 |
EPS (Diluted) | -1.25 |
EBITDA | -39.26M |
EBIT | -39.87M |
Depreciation & Amortization | 612K |
Add to Watchlist
Select watchlists to add or remove SGP